DK129390B - Fremgangsmåde til fremstilling af til parenteral indgift egnede anæstetisk virksomme opløsninger af et steroid. - Google Patents
Fremgangsmåde til fremstilling af til parenteral indgift egnede anæstetisk virksomme opløsninger af et steroid.Info
- Publication number
- DK129390B DK129390B DK317970AA DK317970A DK129390B DK 129390 B DK129390 B DK 129390B DK 317970A A DK317970A A DK 317970AA DK 317970 A DK317970 A DK 317970A DK 129390 B DK129390 B DK 129390B
- Authority
- DK
- Denmark
- Prior art keywords
- preparation
- parenteral administration
- effective solutions
- anaesthetically effective
- steroid
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
- A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J5/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Organic Chemistry (AREA)
- Steroid Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DK642071A DK134996B (da) | 1969-06-20 | 1971-12-29 | 3-Hydroxy-11-ketopregnanderivater til anvendelse som opløsningsfremmende middel for 3alfa-hydroxy-5alfa-pregnan-11,20-dion. |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB3137169 | 1969-06-20 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| DK129390B true DK129390B (da) | 1974-10-07 |
| DK129390C DK129390C (nl) | 1975-02-24 |
Family
ID=10322106
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK317970AA DK129390B (da) | 1969-06-20 | 1970-06-19 | Fremgangsmåde til fremstilling af til parenteral indgift egnede anæstetisk virksomme opløsninger af et steroid. |
Country Status (19)
| Country | Link |
|---|---|
| US (2) | US3714352A (nl) |
| JP (1) | JPS5140135B1 (nl) |
| AT (2) | AT315375B (nl) |
| BE (1) | BE752165A (nl) |
| BR (1) | BR6915173D0 (nl) |
| CA (1) | CA1001073A (nl) |
| CH (1) | CH578016A5 (nl) |
| DE (3) | DE2065513A1 (nl) |
| DK (1) | DK129390B (nl) |
| ES (1) | ES380943A1 (nl) |
| FR (2) | FR2052998B1 (nl) |
| GB (1) | GB1317184A (nl) |
| IE (1) | IE35203B1 (nl) |
| IL (1) | IL34713A (nl) |
| NL (1) | NL169480C (nl) |
| NO (1) | NO133716C (nl) |
| PH (1) | PH11156A (nl) |
| SE (2) | SE406038B (nl) |
| ZA (1) | ZA703861B (nl) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1376892A (en) * | 1970-11-12 | 1974-12-11 | Glaxo Lab Ltd | 2beta-substituted-3alpha-hydroxysteroids and their esters |
| GB1377609A (en) * | 1970-12-17 | 1974-12-18 | Glaxo Lab Ltd | 3alpha-hydroxy-5alpha-pregnane compounds |
| US3917830A (en) * | 1970-12-17 | 1975-11-04 | Glaxo Lab Ltd | Steroidal anaesthetic composition for intraveneous injection |
| GB1377608A (en) * | 1970-12-17 | 1974-12-18 | Glaxo Lab Ltd | 3alpha-hydroxy or acyloxy pregnene-21-ethers |
| US3900561A (en) * | 1970-12-17 | 1975-08-19 | Glaxo Lab Ltd | Pharmaceutical compositions |
| GB1430932A (en) * | 1972-05-05 | 1976-04-07 | Glaxo Lab Ltd | 21-fluoro-pregnanes |
| GB1436324A (en) * | 1972-05-12 | 1976-05-19 | Glaxo Lab Ltd | Anaesthetic 3alpha-hydroxy pregnanes |
| IT1202370B (it) * | 1976-07-12 | 1989-02-09 | Hoffmann La Roche | Soluzioni inietabili in cui l'atti vita' emolitica degli agenti di formazione di micelle naturali e' evitata mediante l'aggiunta di lipoidi e relativi prodotti |
| IT1204778B (it) | 1986-02-04 | 1989-03-10 | Mazzarella Basilio | Formulazioni farmaceutiche iniettabili di principi attivi ad attivita' anestetica generale |
| IE920759A1 (en) * | 1991-03-29 | 1992-10-07 | Generali Costruzioni Srl | Standardized step module for building prefabricated¹staircases, process for producing such module, prefabricated¹staircase and process for assembling prefabricated¹staircases |
| CZ300694A3 (en) * | 1993-12-02 | 1996-05-15 | Akzo Nobel Nv | Substituted 2beta-morpholinandrostane derivatives, process of their preparation, their use for preparing pharmaceutical preparations and pharmaceutical compositions containing thereof |
| US6787530B1 (en) | 1996-08-23 | 2004-09-07 | Monash University | Use of pregnane-diones as analgesic agents |
| US20080234343A1 (en) * | 2004-03-24 | 2008-09-25 | Takeda Pharmaceutical Company | Preparation with Elevated Content |
| AU2019297195A1 (en) | 2018-07-03 | 2021-01-14 | Drawbridge Pharmaceuticals Pty Ltd | Neuroactive steroids and methods of preparation |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR1281205A (fr) * | 1956-12-21 | 1962-01-12 | Organon Nv | Procédé d'obtention de composés de la série du prégnane |
-
1969
- 1969-06-20 GB GB3137169A patent/GB1317184A/en not_active Expired
- 1969-12-15 BR BR215173/69A patent/BR6915173D0/pt unknown
-
1970
- 1970-06-08 ZA ZA703861A patent/ZA703861B/xx unknown
- 1970-06-12 IL IL34713A patent/IL34713A/xx unknown
- 1970-06-15 PH PH11533A patent/PH11156A/en unknown
- 1970-06-17 US US00047163A patent/US3714352A/en not_active Expired - Lifetime
- 1970-06-18 BE BE752165D patent/BE752165A/xx not_active IP Right Cessation
- 1970-06-18 SE SE7008517A patent/SE406038B/xx unknown
- 1970-06-19 DE DE2065513*A patent/DE2065513A1/de not_active Withdrawn
- 1970-06-19 AT AT555570A patent/AT315375B/de active
- 1970-06-19 ES ES380943A patent/ES380943A1/es not_active Expired
- 1970-06-19 CA CA085,973A patent/CA1001073A/en not_active Expired
- 1970-06-19 NL NLAANVRAGE7009002,A patent/NL169480C/nl not_active IP Right Cessation
- 1970-06-19 IE IE800/70A patent/IE35203B1/xx unknown
- 1970-06-19 AT AT710872A patent/AT326826B/de not_active IP Right Cessation
- 1970-06-19 DK DK317970AA patent/DK129390B/da unknown
- 1970-06-19 FR FR7022782A patent/FR2052998B1/fr not_active Expired
- 1970-06-19 FR FR707022783A patent/FR2052999B1/fr not_active Expired
- 1970-06-19 DE DE2065332*A patent/DE2065332A1/de active Pending
- 1970-06-19 DE DE2030402A patent/DE2030402B2/de active Granted
- 1970-06-19 NO NO2396/70A patent/NO133716C/no unknown
- 1970-06-22 CH CH941770A patent/CH578016A5/xx not_active IP Right Cessation
-
1972
- 1972-09-16 JP JP7293152A patent/JPS5140135B1/ja active Pending
-
1973
- 1973-01-05 US US00321274A patent/US3781435A/en not_active Expired - Lifetime
-
1974
- 1974-02-19 SE SE7402197A patent/SE401512B/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| BE752165A (fr) | 1970-12-18 |
| FR2052998A1 (nl) | 1971-04-16 |
| CH578016A5 (nl) | 1976-07-30 |
| DE2065332A1 (de) | 1973-04-05 |
| ES380943A1 (es) | 1973-07-01 |
| GB1317184A (en) | 1973-05-16 |
| ATA710872A (de) | 1975-03-15 |
| IL34713A (en) | 1975-06-25 |
| IE35203L (en) | 1970-12-20 |
| DE2030402B2 (de) | 1975-04-30 |
| PH11156A (en) | 1977-10-28 |
| NO133716C (nl) | 1976-06-16 |
| SE401512B (sv) | 1978-05-16 |
| NL169480C (nl) | 1982-07-16 |
| NO133716B (nl) | 1976-03-08 |
| CA1001073A (en) | 1976-12-07 |
| DE2030402C3 (nl) | 1975-12-11 |
| US3714352A (en) | 1973-01-30 |
| NL7009002A (nl) | 1970-12-22 |
| SE406038B (sv) | 1979-01-22 |
| AT315375B (de) | 1974-05-27 |
| FR2052999A1 (nl) | 1971-04-16 |
| JPS5140135B1 (nl) | 1976-11-01 |
| BR6915173D0 (pt) | 1973-02-08 |
| FR2052998B1 (nl) | 1974-08-30 |
| US3781435A (en) | 1973-12-25 |
| NL169480B (nl) | 1982-02-16 |
| ZA703861B (en) | 1971-02-24 |
| AT326826B (de) | 1975-12-29 |
| IL34713A0 (en) | 1970-08-19 |
| DE2030402A1 (de) | 1971-01-21 |
| DE2065513A1 (de) | 1974-04-04 |
| DK129390C (nl) | 1975-02-24 |
| FR2052999B1 (nl) | 1974-06-14 |
| IE35203B1 (en) | 1975-12-10 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK130306B (da) | Analogifremgangsmåde til fremstilling af S-trialkylphosphinguld-1-thio-β-D-glucopyranosider. | |
| DK136314B (da) | Analogifremgangsmåde til fremstilling af benzamidoethylpiperaziner. | |
| DK137167B (da) | Fremgangsmåde til fremstilling af et stabilt skumdæmpende middel. | |
| DK129390B (da) | Fremgangsmåde til fremstilling af til parenteral indgift egnede anæstetisk virksomme opløsninger af et steroid. | |
| DK118820B (da) | Analogifremgangsmåde til fremstilling af derivater af 5-nitro-2-furyl-isoxazoliner. | |
| DK137955B (da) | Analogifremgangsmåde til fremstilling af morphinan-derivater. | |
| DK126944B (da) | Analogifremgangsmåde til fremstilling af hexahydrobenzindolderivater. | |
| DK125089B (da) | Analogifremgangsmåde til fremstilling af evomonosidderivater. | |
| DK133375B (da) | Analogifremgangsmåde til fremstilling af 1-carbamoyl-3-phenylpyrrolidiner. | |
| DK129167B (da) | Fremgangsmåde til fremstilling af en polymer af et dicyclopentadienderivat. | |
| DK123868B (da) | Analogifremgangsmåde til fremstilling af 3-hydroxycumarin-derivater. | |
| DK128778B (da) | Analogifremgangsmåde til fremstilling af bis-2-carboxy-chromonylderivater. | |
| DK128006B (da) | Analogifremgangsmåde til fremstilling af 11-desacetoxy-wortmannin. | |
| DK115178B (da) | Analogifremgangsmåde til fremstilling af acylderivater af proscillaridin A. | |
| DK123237B (da) | Analogifremgangsmåde til fremstilling af erythromycinasparter. | |
| DK123096B (da) | Analogifremgangsmåde til fremstilling af neriifolinderivater. | |
| DK128737B (da) | Analogifremgangsmåde til fremstilling af 6α-methyl-17α-caproyloxy-19-norprogesteron. | |
| DK123475B (da) | Analogifremgangsmåde til fremstilling af en steroidforbindelse. | |
| DK127107B (da) | Fremgangsmåde til fremstilling af 17α-propadienyl-17β-hydroxy-steroider. | |
| DK124882B (da) | Analogifremgangsmåde til fremstilling af 17α-acyloxy-11β-methyl-19-norpregn-4-en-3,20-dioner. | |
| DK122127B (da) | Analogifremgangsmåde til fremstilling af 3-phenyl-4-acyloxycarbostyriler. | |
| DK123816B (da) | Analogifremgangsmåde til fremstilling af N-phenacylcarbamater. | |
| DK122456B (da) | Fremgangsmåde til fremstilling af quinoxalin-di-N-oxid-aldehyd. | |
| DK139097B (da) | Analogifremgangsmåde til fremstilling af isobutyl-cyclohexenyl-derivater. | |
| DK126991B (da) | Analogifremgangsmåde til fremstilling af 1-phenoxy-3-amino-2-propanolderivater. |